SureTrader SureTrader
Home > Boards > US OTC > Medical - Drugs >

BioMark Diagnostics Inc. (BMKDF)

BMKDF RSS Feed
Add BMKDF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 7/28/2016 8:42:48 PM - Followers: 2 - Board type: Free - Posts Today: 0
BioMark is a Canadian based biotech company developing a metabolic based diagnostic assay that will allow early cancer detection.  BioMark currently holds a number of patents for their technology (patent no. 6811967, and patent applications for Monoclonal antibodies, and Method of Assay).

Their test uses a drug called Amantadine which is given to patients prior to analysis of their urine.  The drug is acetylated using using the enzyme
Spermine/Spermidine N-Acetyl Transferase (SSAT) which has been found in many cancers including lung, breast, melonomas, and GI.  This method will allow for earlier detection of these cancers while minimizing costs. 
 
BioMark-Technology-1

Recent interview with Rahsheed Ahmed on SNN

 



EXECUTIVE TEAM & ADVISORS

Research/Scientific/Clinical

Dr. Daniel S. Sitar – Principal Scientific Advisor/Consultant
Dr. John Yoo – Clinical Oncologist – Co-Chair CancerCare Ontario Head and Neck; Professor Dept. of Oncology Schulich School of Medicine & Dentistry, Western Ontario
Dr. John Schrader – Antibody development – Chair of Biomedical, Research Centre at University of British Columbia
Dr. Horacio Bach – Antibody Engineering UBC
Dr. Safieddin Safavi-Naeini – NSERC/BlackBerry Industrial Research Chair at University of Waterloo

Media Advisory Board

Bill Good – Veteran Broadcaster, Honorary Doctorate of Technology from BCIT

Regulatory

Dr. Ramjiawan from SBRC – Clinical Trial and Regulatory Expertise

Downstream

Jim Elliott – Downstream Technology Advisor and QMS support

North American Management

Rashid Ahmed – Founder, Chief Executive Officer
Dr. Thomas Malcolm – President & Chief Scientific Officer
Brian Cheng – Chief Technical Officer
Abbey Abdiye – Chief Financial Officer (Canada)
Neal Kaplan – Chief Financial Officer (US)
Dr. Kenneth Kohn – Patent Attorney
Gina Huang – Project Director

Medical Delivery Panel

Dr. James Bond – Chief of Thoracic Surgeon Surrey Hospital
Dr. Dwight De Risi – Breast Oncology Surgeon
Dr. Debra Hoffman – Lung Oncology Surgeon

Supporting

Dr. Reuven Gordon and Dr. Fraser Hof Canadian Research Chairs, Uvic
Dr. Andrew Maksymiuk University of Manitoba and Manitoba CancerCare
Dr. Samudra Dissanyake – Scientific Advisor business development
Stan Lee – Chartered Accountant

Auditor

Manning Elliott Accountants & Business Advisors

More information available at http://www.biomarkdiagnostics.com/
 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMKDF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BMKDF News: New Cancer Diagnostic Primed to Change the Industry 03/05/2015 06:09:00 AM
BMKDF News: New Cancer Diagnostic Primed to Change the Industry 03/05/2015 06:09:00 AM
PostSubject
#19   BioMark raw data collection complete on 200 patient MichaelVest 07/28/16 08:42:48 PM
#18   Expect commercializing of BioMark's early detection red alert MichaelVest 04/02/16 07:25:36 PM
#17   BioMark receives approval from Health Canada and the MichaelVest 04/02/16 07:23:32 PM
#16   Great Video BioMark Cancer Survivorship Program MichaelVest 03/08/16 07:18:14 PM
#15   A good article regarding BioMark MichaelVest 03/08/16 07:12:30 PM
#14   BioMark Announces Progress MichaelVest 03/08/16 07:09:32 PM
#12   Quest for Game Changing Lung Cancer Diagnostic Assay Video MichaelVest 10/04/15 07:54:05 PM
#11   BioMark expects to begin study of its' assay MichaelVest 10/04/15 07:35:32 PM
#10   BioMark receives clearance from Health Canada to commence MichaelVest 10/04/15 07:31:40 PM
#9   Interim financial report June 2015 MichaelVest 08/27/15 11:53:10 AM
#8   Dr. Thomas Malcolm to head U.S. operations. MichaelVest 08/27/15 11:49:00 AM
#7   BioMark lays out plan for U.S. MichaelVest 08/27/15 11:43:48 AM
#6   BioMark is four weeks out with data on MichaelVest 08/27/15 11:29:25 AM
#5   Two patent applications for BioMark below: MichaelVest 06/16/15 10:07:13 PM
#4   Company currently holds patent for their tech. MichaelVest 06/16/15 09:00:48 PM
#3   From Nov. 2014 but good information on what MichaelVest 06/16/15 08:03:06 PM
#2   Anyone trading this yet? GoBison 03/02/15 10:00:29 AM
#1   BioMark Announces Grant Funded Partnership With TMIC jupp 03/02/15 09:07:51 AM
PostSubject